Cost Analysis Study of Topical Anti-Acne Drugs Currently Available in Indian Pharmaceutical Market
Acne vulgaris is a chronic inflammatory skin disease that affects approximately 90% individuals between puberty and 30 years of age at some point with peak prevalence in adolescence. According to Global Burden of Disease study conducted in 187 countries in 2010, acne is among top ten most p...
Saved in:
| Main Authors: | Neelomjyoti Gohain, Hiteswar Saikia, Meghali Chaliha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Krupanidhi College of Pharmacy
2024-03-01
|
| Series: | Journal of Pharmaceutical Research |
| Online Access: | https://jopcr.com/articles/cost-analysis-study-of-topical-anti-acne-drugs-currently-available-in-indian-pharmaceutical-market |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost Variation Analysis of Hypolipidemic Drugs Currently Available in Indian Pharmaceutical Market
by: Prajnyan Prasad Kalita, et al.
Published: (2024-06-01) -
Cost Analysis of DPP4 and SGLT2 Inhibitors - “Dilemma of the Prescribing Physician - Which Brand to Choose?”
by: Hiteswar Saikia, et al.
Published: (2024-06-01) -
Analysis of Package Inserts Available in the Indian Market
by: Alay Patel, et al.
Published: (2024-06-01) -
Efficacy of Probiotic Supplements and Topical Applications in the Treatment of Acne: A Scoping Review of Current Results
by: Sutema IAMP, et al.
Published: (2025-01-01) -
Topical clindamycin for acne vulgaris: analysis of gastrointestinal events
by: Natalia M. Pelet del Toro, et al.
Published: (2024-12-01)